Showing results (41-50 of 98) with videos related to
Sort By:
Pageof 10
Ebiomedicine|September 3, 2021
Automated assessment of CD8+ T-lymphocytes and stroma fractions complement conventional staging of colorectal cancerDan Jiang, Tarjei S Hveem, Mark Glaire, et al.Oncology|March 8, 2007
Identification of an oligopeptide binding to hepatocellular carcinomaAkira Shimizu, Fukuto Maruta, Noriyuki Akita, et al.Clinical Pharmacokinetics|October 20, 2005
Single-dose clinical pharmacokinetic studies of gefitinibHelen C Swaisland, Robert P Smith, Alison Laight, et al.Nature Reviews. Cancer|April 4, 2008
The challenge of cancer control in AfricaRebecca J Lingwood, Peter Boyle, Alan Milburn, et al.Journal of Human Genetics|November 26, 2010
Cyclin D1 rare variants in UK multiple adenoma and early-onset colorectal cancer patientsCarolina Bonilla, Jérémie H Lefèvre, Bruce Winney, et al.Cancer Science|September 21, 2006
Identification of oligopeptides binding to peritoneal tumors of gastric cancerNoriyuki Akita, Fukuto Maruta, Leonard W Seymour, et al.Oncogene|August 13, 2002
Breast cancer cell-derived EMMPRIN stimulates fibroblast MMP2 release through a phospholipase A(2) and 5-lipoxygenase catalyzed pathwayPaul M Taylor, Richard J Woodfield, Matthew N Hodgkin, et al.Proceedings of the National Academy of Sciences of the United States of America|March 24, 2010
HR23B is a biomarker for tumor sensitivity to HDAC inhibitor-based therapyOmar Khan, Susan Fotheringham, Victoria Wood, et al.Journal of Human Genetics|August 10, 2012
Role of rare variants in undetermined multiple adenomatous polyposis and early-onset colorectal cancerJérémie H Lefevre, Carolina Bonilla, Chrystelle Colas, et al.Scientific Reports|March 13, 2025
Activin A affects colorectal cancer progression and immunomodulation in a stage dependent mannerMark B Wiley, Jessica Bauer, Valentina Alvarez, et al.Pageof 10